Remuneration

EQS-News: NOTICE TO CONVENE MULTITUDE SE’S ANNUAL GENERAL MEETING OF SHAREHOLDERS

Retrieved on: 
Wednesday, April 10, 2024

The Board of Directors proposes to the Annual General Meeting that, for the financial year 2023, a dividend of EUR 0.19 per share be distributed.

Key Points: 
  • The Board of Directors proposes to the Annual General Meeting that, for the financial year 2023, a dividend of EUR 0.19 per share be distributed.
  • Shareholders, who are registered in the shareholders’ register of the Company, and who wish to participate in the General Meeting, must register for the meeting by giving prior notice of participation as instructed below.
  • Shareholders may participate in the General Meeting of Shareholders and exercise their rights at the meeting by way of proxy representation.
  • On the date of this notice to the Annual General Meeting of Shareholders, dated 28 March 2024, the total number of shares in Multitude SE is 21,723,960 and each of these shares carries one vote.

EQS-News: Wacker Neuson Group: strong revenue and earnings growth in fiscal 2023 – focus on Strategy 2030

Retrieved on: 
Wednesday, April 10, 2024

Earnings before interest and taxes (EBIT) increased even faster at 35.4 percent and reached EUR 273.2 million (2022: EUR 201.8 million).

Key Points: 
  • Earnings before interest and taxes (EBIT) increased even faster at 35.4 percent and reached EUR 273.2 million (2022: EUR 201.8 million).
  • “Fiscal 2023 began with dynamic growth, which increasingly gave way to downward trends across many sectors of the economy in the second half of the year.
  • Double-digit growth – breakdown of revenue by region: Revenue in Europe (EMEA) increased by 18.3 percent to EUR 2,022.4 million (2022: EUR 1,709.9 million).
  • At EUR 76.0 million, revenue in Asia-Pacific fell by 8.9 percent in fiscal 2023 (2022: EUR 83.4 million).

PolyPeptide publishes invitation to the annual General Meeting 2024

Retrieved on: 
Wednesday, April 10, 2024

Baar, 19 March 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients,

Key Points: 
  • Baar, 19 March 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients,
    published today the invitation to the third annual General Meeting which will take place on 10 April 2024 at the Chollerhalle in Zug.
  • At PolyPeptide Group AG’s (the “Company”) third annual General Meeting which will take place on 10 April 2024 at the Chollerhalle in Zug (the “AGM 2024”), six current members of the Board of Directors will stand for re-election.
  • Dorothee A. Deuring has decided not to stand for re-election as a member of the Board of Directors.
  • The Board of Directors further proposes to the AGM 2024 the deletion of art.

Nordea's Annual General Meeting 2024 and decisions of the statutory Board meeting

Retrieved on: 
Wednesday, April 10, 2024

PricewaterhouseCoopers Oy was re-elected as the auditor for the period until the end of the next AGM.

Key Points: 
  • PricewaterhouseCoopers Oy was re-elected as the auditor for the period until the end of the next AGM.
  • The AGM decided that the remuneration of the auditor is to be paid according to the invoice approved by the Company.
  • The authorisation remains in force and effect until the earlier of (i) the end of the next annual general meeting of the Company or (ii) 18 months from the resolution of the AGM 2024.
  • The authorisation remains in force and effect until the earlier of (i) the end of the next annual general meeting of the Company or (ii) 18 months from the AGM 2024.

7th Annual General Meeting: Shareholders approve all proposals

Retrieved on: 
Wednesday, April 10, 2024

The seventh Annual General Meeting of Galenica Ltd. was held on 10 April 2024 at the Kursaal in Bern.

Key Points: 
  • The seventh Annual General Meeting of Galenica Ltd. was held on 10 April 2024 at the Kursaal in Bern.
  • The shareholders approved all the proposals put forward by the Board of Directors.
  • The Annual General Meeting also approved the dividend at the prior-year level of CHF 2.20 per share proposed by the Board of Directors.
  • The dividend for the 2023 financial year will be paid to shareholders from 16 April 2024.

49th Annual General Meeting of BELIMO Holding AG Approves All Motions

Retrieved on: 
Wednesday, April 10, 2024

The 49th Annual General Meeting of BELIMO Holding AG was held on March 25, 2024.

Key Points: 
  • The 49th Annual General Meeting of BELIMO Holding AG was held on March 25, 2024.
  • The shareholders approved the proposed amendments to the Articles of Incorporation of BELIMO Holding AG, which are mainly in response to revisions to the Swiss company law.
  • Taking these amendments into account, the proposed maximum remuneration of the Board of Directors from January 1, 2024, to the 2024 Annual General Meeting, and from the 2024 Annual General Meeting to the 2025 Annual General Meeting, were approved.
  • The shares of BELIMO Holding AG have been traded on the SIX Swiss Exchange since 1995 (BEAN).

RALLYE S.A.: Annual results 2023

Retrieved on: 
Wednesday, April 10, 2024

In 2023, some of Rallye’s creditors exercised their right to take over the Casino shares held in a fiduciary-trusts, resulting in a €30m reduction in financial debt.

Key Points: 
  • In 2023, some of Rallye’s creditors exercised their right to take over the Casino shares held in a fiduciary-trusts, resulting in a €30m reduction in financial debt.
  • In 2023, the change of €265m in IFRS restatements corresponds to the accelerated amortization of liabilities under the IFRS 9 standard as part of the abandonment of the principle of going concern.
  • Financial expenses in 2023 relate to interest on financial debts amounting to - €183m and a provision for impairment on Casino securities for -€1,915m.
  • Shareholders' equity amounted to a negative amount of -€3,221m at 31 December 2023, compared with a negative amount of -€601m at 31 December 2022.

TRX Gold Reports 2023 Annual Meeting Voting Results

Retrieved on: 
Friday, April 5, 2024

Appointment of Dale Matheson Carr-Hilton Labonte LLP,

Key Points: 
  • Appointment of Dale Matheson Carr-Hilton Labonte LLP,
    and authorize the directors to fix the remuneration of the auditors.
  • Stephen Mullowney, TRX Gold Chief Executive Officer states, “We are very pleased with the voter turnout.
  • It’s great to see the continued engagement and support from our shareholders.
  • TRX Gold had an exceptional year of growth in fiscal 2023 and we expect more of the same for fiscal 2024”.

United Lithium Announces Results from the 2024 Annual General and Special Meeting of Shareholders

Retrieved on: 
Monday, April 1, 2024

At the Meeting, the shareholders of the Company also approved:

Key Points: 
  • At the Meeting, the shareholders of the Company also approved:
    the re-appointment of Dale Matheson Carr-Hilton LaBonte LLP as the auditor of the Company for the ensuing year and authorized the directors to fix their remuneration; and
    the Company’s new Compensation Plan.
  • The total number of common shares of United Lithium represented by shareholders in person or by proxy at the Meeting was 5,771,433 common shares, representing 14.05% of the total issued and outstanding common shares at the record date for the Meeting.
  • The Company also announces the departure of Anoop Prihar, Vice President, Corporate Development.
  • The board of directors thank Mr. Prihar for his service and wish him success in all his future endeavors.

Sirona Biochem Announces 2023 Annual Meeting Results

Retrieved on: 
Thursday, March 28, 2024

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on March 28, 2024.

Key Points: 
  • VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on March 28, 2024.
  • The total number of shares represented by shareholders present in person and by proxy at the Meeting was 26,722,196, representing 10.52% of Sirona's issued and outstanding Common Shares.
  • All matters put forward to shareholders for consideration and approval, as set out in the Company's Management Information Circular dated 22nd of February, 2024, were approved by the requisite majority of votes cast at the Meeting.
  • Sirona would like to thank all shareholders for their continued support.